|
DHG: Business result in Q3/08
DHG Pharmaceutical Joint – Stock Company (DHG Pharma) has explained business result in Q3/08 as follows:
Adjusting figures in Q2/08: the company added provision of bad debt in Q2 with the amount of VND1,562,930,930,227. Thus corporate expenses increased and profit before tax decreased.
Profit after tax in Q3/08 increased 13% compared to that in Q2/08.
|
|
2008 |
Difference |
Rate |
|
Q2 (adjusted) |
Q3 |
|
Profit before tax |
32,765,600,858 |
37,733,236,731 |
4,967,635,873 |
15.16% |
|
Income tax |
3,301,307,058 |
3,968,909,423 |
667,602,365 |
20.22% |
|
Profit after tax |
29,464,293,800 |
33,764,327,308 |
4,300,033,509 |
14.59% |
|
Profit after tax of minorities |
228,547,699 |
726,375,028 |
497,809,329 |
217.81% |
|
Profit after tax of parent company’s shareholders |
29,235,746,101 |
33,037,970,280 |
3,802,224,180 |
13.01% |
Reasons:
In Q3/08, the company strengthened sale and marketing activities, research and development of the potential markets in order to increase market share. In addition, the company launched new products to attract more customers.
HoSE
|
